Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors
Guo‐Ming Shi, Jiping Wang, Xiaowu Huang, Xiaoyong Huang, Yifeng He, Yuan Ji, Yi Chen, Dong Wu, Jia‐Cheng Lu, Qi‐Man Sun, Weiren Liu, Ting Wang, Liu‐Xiao Yang, Yingyong Hou, Ying‐Hong Shi, Jian Sun, Yong‐Sheng Xiao, Zheng Wang, Jia Fan, Monica M. Bertagnolli, Jian Zhou
Abstract
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
MedicineImmunotherapyLiver transplantationLigand (biochemistry)TransplantationOncologyImmunologyCancer researchInternal medicineImmune systemReceptorHepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus StudiesDrug Transport and Resistance Mechanisms